These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15578164)

  • 21. A component tracking algorithm for accelerated and improved liquid chromatography-mass spectrometry method development.
    Fredriksson MJ; Petersson P; Axelsson BO; Bylund D
    J Chromatogr A; 2010 Dec; 1217(52):8195-204. PubMed ID: 21081230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in high-throughput mass spectrometry.
    Morand KL; Burt TM; Regg BT; Tirey DA
    Curr Opin Drug Discov Devel; 2001 Nov; 4(6):729-35. PubMed ID: 11899612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-performance liquid chromatography/NMR spectrometry/mass spectrometry: further advances in hyphenated technology.
    Holt RM; Newman MJ; Pullen FS; Richards DS; Swanson AG
    J Mass Spectrom; 1997 Jan; 32(1):64-70. PubMed ID: 9008869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fast liquid chromatography combined with mass spectrometry for the analysis of metabolites and proteins in human body fluids.
    Kortz L; Helmschrodt C; Ceglarek U
    Anal Bioanal Chem; 2011 Mar; 399(8):2635-44. PubMed ID: 21253711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A simple method for monitoring the cysteine content in synthetic peptides.
    Horváti K; Bõsze S; Hudecz F; Medzihradszky-Schweiger H
    J Pept Sci; 2008 Jul; 14(7):838-44. PubMed ID: 18265426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of disulfide bridges in a cardiotoxic peptide by electrospray ionization.
    Krishnamurthy T; Hauer CR; Prabhakaran M; Freedy JG; Hayashi K
    Biol Mass Spectrom; 1994 Dec; 23(12):719-26. PubMed ID: 7841206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mass spectrometry of macromolecules: has its time now come?
    Senko MW; McLafferty FW
    Annu Rev Biophys Biomol Struct; 1994; 23():763-85. PubMed ID: 7919798
    [No Abstract]   [Full Text] [Related]  

  • 28. Mass spectrometry provides sweet inspiration.
    Freeze H
    Nat Biotechnol; 2003 Jun; 21(6):627-9. PubMed ID: 12776147
    [No Abstract]   [Full Text] [Related]  

  • 29. A modular flow reactor for performing Curtius rearrangements as a continuous flow process.
    Baumann M; Baxendale IR; Ley SV; Nikbin N; Smith CD; Tierney JP
    Org Biomol Chem; 2008 May; 6(9):1577-86. PubMed ID: 18421389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart-cutting two-dimensional (size exclusion x reversed phase) liquid chromatography-mass spectrometry analysis of flavonol glycosides from leaves of Maytenus ilicifolia.
    de Souza LM; Cipriani TR; Sant'ana CF; Iacomini M; Gorin PA; Sassaki GL
    J Chromatogr A; 2009 Jan; 1216(1):99-105. PubMed ID: 19062030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioanalytical strategies for developing highly sensitive liquid chromatography/tandem mass spectrometry based methods for the peptide GLP-1 agonists in support of discovery PK/PD studies.
    Zhang H; Xin B; Caporuscio C; Olah TV
    Rapid Commun Mass Spectrom; 2011 Nov; 25(22):3427-35. PubMed ID: 22002697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversed-phase HPLC and hyphenated analytical strategies for peptidomics.
    Hesse AM; Ndiaye S; Vinh J
    Methods Mol Biol; 2011; 789():203-21. PubMed ID: 21922410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of neuropeptides by size-exclusion HPLC linked to electrospray ionization mass spectrometry.
    Silberring J
    Methods Mol Biol; 1997; 73():129-40. PubMed ID: 9031204
    [No Abstract]   [Full Text] [Related]  

  • 34. Advances in high-throughput high-performance liquid chromatography and "purification-friendly" combinatorial library design strategies.
    Schefzick S
    Adv Chromatogr; 2007; 45():197-213. PubMed ID: 17626560
    [No Abstract]   [Full Text] [Related]  

  • 35. Current applications of liquid chromatography/mass spectrometry in pharmaceutical discovery after a decade of innovation.
    Ackermann BL; Berna MJ; Eckstein JA; Ott LW; Chaudhary AK
    Annu Rev Anal Chem (Palo Alto Calif); 2008; 1():357-96. PubMed ID: 20636083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LC-MS systems for quantitative bioanalysis.
    van Dongen WD; Niessen WM
    Bioanalysis; 2012 Oct; 4(19):2391-9. PubMed ID: 23088465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changing requirements of purification as drug discovery programs evolve from hit discovery.
    Isbell J
    J Comb Chem; 2008; 10(2):150-7. PubMed ID: 18181578
    [No Abstract]   [Full Text] [Related]  

  • 38. Global metabolic profiling using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
    Qi Y; Song Y; Gu H; Fan G; Chai Y
    Methods Mol Biol; 2014; 1198():15-27. PubMed ID: 25270920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a high-speed, multiplexed sample-delivery instrument for LC-MS/MS bioanalysis.
    Janiszewski J; Schneider R; Kapinos B; West M; Funk C; Federico J; Umland J; Piotrowski M; Mitchell W; Zhang H; Zelesky V; Gobey J; Whalen K; Liston T; Troutman M
    Bioanalysis; 2012 May; 4(9):1039-56. PubMed ID: 22612685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liquid chromatography-mass spectrometry in in vitro drug metabolite screening.
    Tolonen A; Turpeinen M; Pelkonen O
    Drug Discov Today; 2009 Feb; 14(3-4):120-33. PubMed ID: 19059358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.